1-11 of 11
Maria Jose Sayas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nationwide Laboratory Network for AML Cross-Validated NGS Studies: Results from a Real-Life Cohort of the Pethema Group

Claudia Sargas, Rosa Ayala, Carmen Chillon, Maria Jose Larrayoz, Estrella Carrillo, Cristina Bilbao, Manuel Yébenes, Marta Llop, Inmaculada Rapado, Ramon Garcia-Sanz, Iria Vazquez, Elena Soria, Santiago Sánchez-Sosa, Kamila Janusz, Carmen Botella, Josefina Serrano, David Martinez-Cuadron, Juan-Miguel Bergua, Maria Luz Amigo, Pilar Martinez Sanchez, Mar Tormo, Teresa Bernal, Pilar Herrera-Puente, Raimundo García-Boyero, Lorenzo Algarra, Maria Jose Sayas, Lisette Costilla-Barriga, Esther Pérez-Santolalla, Inmaculada Marchante, Esperanza Lavilla-Rubira, Víctor Noriega, Juan Manuel Alonso Dominguez, Miguel A. Sanz, Joaquín Sánchez, María Teresa Gómez-Casares, Jose A. Perez-Simon, María José Calasanz, Marcos González, Joaquín Martínez-López, Eva Barragán, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1302.
DOI: https://doi.org/10.1182/blood-2021-152353
Published: 2021
Journal Articles

Venetoclax Therapy in a Heavily Treated Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia: Update of the Pethema Registry Experience

Jorge Labrador, Miriam Saiz-Rodríguez, Maria Dunia De Miguel, Almudena De Laiglesia, Carlos Rodriguez, María Belén Vidriales, Manuel Pérez-Encinas, Maria Jose Sanchez, Rebeca Cuello, Alicia Roldán Pérez, Susana Vives, Gonzalo Benzo Callejo, Mercedes Colorado Araujo, María García-Fortes, Maria Jose Sayas, Carmen Olivier, Isabel Recio, Diego Conde, Alvaro Bienert Garcia, Maria Vahi, Carmen Muñoz García, Cristina Seri, Mar Tormo, Ferran Vall-llovera, Maria Angeles Foncillas, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2325.
DOI: https://doi.org/10.1182/blood-2021-150231
Published: 2021
Journal Articles

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Bruno Paiva, PhD, María Belén Vidriales, Maria Desamparados Sampere Talens, Fabian Tarin, Enrique Colado, Celina Benavente, María Teresa Cedena, MD, Joaquin Sanchez, MD, Teresa Caballero-Velázquez, MD PhD, Lourdes Cordon, David Martínez-Cuadron, MD, Teresa Bernal del Castillo, MD PhD, Carmen Botella, Sofia Grille, MDPhD, Josefina Serrano, MD, Carlos Rodriguez, Jesús Lorenzo Algarra, Juan Manuel Alonso Dominguez, MD PhD MSc, Maria Luz Amigo, MD, Manuel BARRIOS García, MDPhD, Raimundo García-Boyero, MD, Mercedes Colorado, MD, Jaime Perez De Oteyza, MDPhD, Manuel Perez Encinas, MD, Lissette Del Pilar Costilla, MD, Maria Jose Sayas, Olga Pérez-López, Marcos González, Jose A. Perez-Simon, MD PhD, Joaquin Martinez-Lopez, MD PhD, Claudia Lucia Sossa, Alberto Orfao, MD PhD, Jesús F. San-Miguel, Miguel Sanz, MD PhD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–15.
DOI: https://doi.org/10.1182/blood-2020-134349
Published: 2020
Journal Articles

Measurable Residual Disease (MRD) in Elderly Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial

Catia Patricia Simoes, MD, Bruno Paiva, PhD, David Martínez-Cuadron, MD, Juan-Miguel Bergua, MD, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD, Pilar Martinez, MD, Josefina Serrano, MD, Pilar Herrera, MD, Fernando Ramos, MDPhD, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, Jose Luiz Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, José F. Falantes, Maria Jose Sayas, Rosa Ayala, MD PhD, Joaquin Martinez-Lopez, MD, Sara Villar, María José Calasanz, PhD, Felipe Prosper, MD, Jesús F. San-Miguel, Miguel A. Sanz, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32.
DOI: https://doi.org/10.1182/blood-2020-134651
Published: 2020
Journal Articles

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The Pethema Registry Experience

Jorge Labrador, Miriam Saiz-Rodríguez, Maria Dunia De Miguel, MD, María Belén Vidriales, Manuel Perez Encinas, MD, Maria Jose Sanchez, MD, Rebeca Cuello, MD, Alicia Roldán Pérez, Susana Vives, MD, Gonzalo Benzo Callejo, Mercedes Colorado Araujo, María García-Fortes, Maria Jose Sayas, Carmen Olivier, Isabel Recio, Diego Conde Royo, Alvaro Bienert Garcia, MD, Maria Vahi, Carmen Muñoz García, PhD, Cristina Seri, MD, Mar Tormo, MD, Ferran Vall-llovera, Maria Angeles Foncillas, David Martínez-Cuadron, MD, Miguel A. Sanz, MD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
DOI: https://doi.org/10.1182/blood-2020-141191
Published: 2020
Journal Articles

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

Rosa M. Ayala, MD PhD, Inmaculada Rapado, David Martínez-Cuadron, MD, Esther Onecha, PhD, Laura Rufian, Miss, Alexandra Juarez, Juan Bergua Burgues, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD PhD, Pilar Martinez, MD, Josefina Serrano, Pilar Herrera, MD, Fernando Ramos, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, MD, Jose Luis Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, MD, José F. Falantes, Maria Jose Sayas, Bruno Paiva, PhD, Eva Barragán, Felipe Prosper, MD PhD, Miguel A. Sanz, Joaquin Martinez Lopez, MD PhD, Pau Montesinos Fernandez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3891.
DOI: https://doi.org/10.1182/blood-2019-127187
Published: 2019
Journal Articles

Extranodal Natural Killer/T-Cell Lymphoma Nasal Type in 87 Cases from Spain: Clinical Presentation, Treatment and Prognostic Factors. Study from the Geltamo Group

Eva González-Barca, MD PhD, Alejandro Martín, MD, Jose Luis Bello, Juan Miguel Miguel Bergua Burgues, Carlos Panizo, MDPhD, Maite Encuentra, Ana Monter Rovira, Raul Cordoba, MD PhD, Mariana Bastos, MD, Jose Javier Sanchez Blanco, Pilar Gomez, Ana Marin Niebla, PhD, Sonia González de Villambrosia, MD, Maria Jose Sayas, Hugo Daniel Luzardo Henriquez, MD, Maria De La Cruz Viguria Alegria, Blanca Sanchez-Gonzalez, MD PhD, Monica Roig, Jaime Perez De Oteyza, MDPhD, Elena Cabezudo, Lourdes Escoda, MD, Raquel de Oña, Josë Antonio Queizan, Maria Stefania Infante, Ana Muntañola Prat, Andres Lopez
Journal: Blood
Blood (2018) 132 (Supplement 1): 1637.
DOI: https://doi.org/10.1182/blood-2018-99-110792
Published: 2018
Journal Articles

Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial

Bruno Paiva, MD PhD, David Martínez-Cuadron, MD, Juan Miguel Miguel Bergua Burgues, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD PhD, Pilar Martínez-Sánchez, MD, Josefina Serrano, MD, Pilar Herrera, MD, Fernando Ramos, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, MD, Jose Luiz Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, MD, José F. Falantes, MD, Maria Jose Sayas, Juana Merino, Ana Alfonso, MD, Felipe Prosper, MD PhD, Jesus F San-Miguel, MD PhD, Miguel A. Sanz, MD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 433.
DOI: https://doi.org/10.1182/blood-2018-99-113299
Published: 2018
Journal Articles

A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

Juan Miguel Bergua, Pau Montesinos, MD, David Martinez-Cuadrón, MD, Pascual Fernández-Abellán, MD, Josefina Serrano, MD, María José Sayas, MD, Julio Prieto-Fernandez, MD, Raimundo Garcia, MD, Ana Julia Garcia-Huerta, MD, Manuel Barrios, MD, Cristina Pérez-López, MD, Manuel Perez-Encinas, MD, Adriana Siemele, MD, Gabriela Rodriguez-Macias, MD, Pilar Herrera-Puente, Rebeca Rodríguez-Veiga, MD, Maria Pilar Martinez-Sanchez, MD, Maria Lourdes Amador-Barciela, MD, Miguel A. Sanz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1049.
DOI: https://doi.org/10.1182/blood.V124.21.1049.1049
Published: 2014
Journal Articles

Long-Term Outcome Of 151 Patients With Relapsed APL Receiving Second-Line With Chemotherapy Or Arsenic Trioxide-Based Regimens

Pau Montesinos, David Martínez-Cuadrón, Concha Rivas, Salut Brunet, MD, PhD, José David González-San Miguel, Vicente Rubio, Cristina Pérez, Félix Manso, Pedro Sánchez-Godoy, Lourdes Escoda, Elena Amutio, Mark Zijlmans, MD, Mar Tormo, MD, Marcos González, MD, Chelo Rayón, María José Sayas, Josep-Maria Ribera, MD, PhD, Guillermo Deben, José Hernández-Martín, Jordi Esteve, MD, PhD, Edo Vellenga, MD, PhD, Miguel Sanz
Journal: Blood
Blood (2013) 122 (21): 3922.
DOI: https://doi.org/10.1182/blood.V122.21.3922.3922
Published: 2013
Journal Articles

Minimal Residual Diease Evaluation By Flow Cytometry Is a Complementary Tool To Cytogenetics For Treatment Decision In Acute Myeloid Leukemia

María-Belén Vidriales, MD, PhD, Estefania Perez-Lopez, Carlota Pegenaute, MD, Marta Castellanos, MD, Jose Juan Perez, Mauricio A Chandía, MD, Joaquín Díaz-Mediavilla, Consuelo Rayon, Natalia Heras, MD, PhD, Pascual Fernandez, Miguel Cabezudo, Alfonso Garcia de Coca, MD, Jose M Alonso, MD, Carmen Olivier, MD, Jesus Hernandez, MD, Marcos González, MD, Guillermo Martin, Rosa Fernandez, Julio García-Suarez, Magdalena Garcia, Maria-Jose Sayas, Alberto Orfao, Jesus F San Miguel
Journal: Blood
Blood (2013) 122 (21): 2576.
DOI: https://doi.org/10.1182/blood.V122.21.2576.2576
Published: 2013